In patients with congestive heart failure (CHF), remote hemodynamic monitoring can
reduce heart failure exacerbation and mortality. In this study, we compared the effectiveness
of remote hemodynamic monitoring with that of standard care in the management of patients
with CHF. The remote monitoring group included 7,733 patients, and the control group
included 7,567 patients. Chi-square test and I-square statistics were used to assess
heterogeneity. Risk ratios (RRs) were calculated using fixed-effects and random-effects
methods to determine the risk of all-cause hospitalization and CHF-related hospitalization
(primary outcomes) and all-cause mortality and device outcomes (secondary outcomes).
Pooled findings indicated a 7% lower risk of all-cause hospitalization in the remote
monitoring group than that in the control group (RR 0.93, 95% confidence interval
[CI] 0.89 to 0.98, p = 0.004). The results also revealed a 32% lower risk of CHF-related
hospitalization in the remote monitoring group than that in the control group (RR
0.68, 95% CI 0.65 to 0.71, p <0.001). No statistically significant differences were
noted between the groups in terms of all-cause mortality (RR 0.97, 95% CI 0.87 to
1.07, p = 0.53) and device outcomes (RR 1.23 95% CI 0.92 to 1.65, p = 0.16). These
results provided evidence regarding the comparable effectiveness of remote CHF monitoring
and routine care. The current evidence is insufficient to introduce remote hemodynamic
CHF monitoring; however, our results suggest that the integration of telemonitoring
systems with routine medical management may improve heart failure care.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Chronic heart failure.Aust Prescr. 2017; 40: 128-136
- Heart failure: diagnosis, management and utilization.J Clin Med. 2016; 5: 62
- Global public health burden of heart failure.Card Fail Rev. 2017; 3: 7-11
- Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials.Eur J Heart Fail. 2017; 19: 426-433
- Remote monitoring of implantable cardiac devices in heart failure patients: a systematic review and meta-analysis of randomized controlled trials.Heart Fail Rev. 2020; 25: 469-479
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ. 2021; 372: n71
- A power formula for the Mantel–Haenszel test for differential item functioning.Appl Psychol Meas. 2015; 39: 373-388
- Statistical notes for clinical researchers: chi-squared test and Fisher's exact test.Restor Dent Endod. 2017; 42: 152-155
- Introduction to systematic review and meta-analysis.Korean J Anesthesiol. 2018; 71: 103-112
- Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.Lancet. 2011; 377: 658-666
- Association of ambulatory hemodynamic monitoring of heart failure with clinical outcomes in a concurrent matched cohort analysis.JAMA Cardiol. 2019; 4: 556-563
- Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the reducing decompensation events utilizing intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial.Congest Heart Fail. 2011; 17: 248-254
- CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: a single center experience.JRSM Cardiovasc Dis. 2019; 82048004019833290
- Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “Real-World” clinical practice.J Am Coll Cardiol. 2017; 69: 2357-2365
- A remote medication monitoring system for chronic heart failure patients to reduce readmissions: a two-arm randomized Pilot study [published correction appears in J Med Internet Res 2019;21:e13125].J Med Internet Res. 2016; 18: e91
- Remote monitoring for heart failure: assessing the risks of readmission and mortality.Am Heart J Plus. 2021; 10100045
- Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.Circulation. 2012; 125: 2985-2992
- Remote management of heart failure using implantable electronic devices.Eur Heart J. 2017; 38: 2352-2360
- Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.Circ Heart Fail. 2020; 13e006863
- Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.J Card Fail. 2008; 14: 816-823
- Pulmonary artery pressure–guided heart failure management reduces 30-day readmissions.Circ Heart Fail. 2016; 9e002600
- Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study.J Am Coll Cardiol. 2008; 51: 1073-1079
- Effects of home versus hospital-based exercise training in chronic heart failure.Int J Cardiol. 2012; 158: 296-298
- Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.Circulation. 2011; 124: 1719-1726
- The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).Europace. 2016; 18: 428-435
- Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction.J Am Coll Cardiol. 2017; 70: 1875-1886
- INvestigation on routine follow-up in congestive heart failure patients with remotely monitored implanted cardioverter defibrillators SysTems (InContact).BMC Cardiovasc Disord. 2018; 18: 131
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.Lancet. 2014; 384: 583-590
- Hemodynamic-guided heart-failure management using a wireless implantable sensor: infrastructure, methods, and results in a community heart failure disease-management program.Clin Cardiol. 2017; 40: 170-176
- Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device.J Card Fail. 2015; 21: 240-249
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.Lancet. 2021; 398: 991-1001
- A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices.Europace. 2015; 17: 1276-1281
- Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.Int J Clin Pract. 2016; 70: 569-576
- Remote hemodynamic-guided therapy of patients with recurrent heart failure following cardiac resynchronization therapy.J Am Heart Assoc. 2021; 10e017619
- Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in heart failure: a systematic review and meta-analysis of randomized controlled trials and real-world studies.J Geriatr Cardiol. 2018; 15: 298-309
- Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials.Heart Fail Rev. 2022; 27: 1281-1300
Article info
Publication history
Published online: February 07, 2023
Received in revised form:
October 17,
2022
Received:
May 16,
2022
Footnotes
Funding: none.
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.
